Mark Sheptoff Financial Planning LLC Trims Holdings in DaVita Inc. (NYSE:DVA)

Mark Sheptoff Financial Planning LLC lessened its stake in DaVita Inc. (NYSE:DVA) by 39.1% in the third quarter, Holdings Channel reports. The institutional investor owned 400 shares of the company’s stock after selling 257 shares during the quarter. Mark Sheptoff Financial Planning LLC’s holdings in DaVita were worth $66,000 as of its most recent SEC filing.

Other institutional investors have also recently added to or reduced their stakes in the company. Erste Asset Management GmbH acquired a new position in DaVita during the 3rd quarter worth $454,000. Maverick Capital Ltd. lifted its position in shares of DaVita by 11.5% during the third quarter. Maverick Capital Ltd. now owns 12,886 shares of the company’s stock worth $2,112,000 after purchasing an additional 1,333 shares during the last quarter. Edgestream Partners L.P. acquired a new position in DaVita in the third quarter worth about $5,441,000. Caisse DE Depot ET Placement DU Quebec bought a new stake in DaVita in the third quarter valued at about $1,820,000. Finally, PDT Partners LLC raised its stake in DaVita by 25.8% during the third quarter. PDT Partners LLC now owns 26,887 shares of the company’s stock valued at $4,408,000 after buying an additional 5,506 shares in the last quarter. 90.12% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, CEO Javier Rodriguez sold 9,881 shares of the company’s stock in a transaction dated Friday, September 13th. The shares were sold at an average price of $162.85, for a total value of $1,609,120.85. Following the completion of the sale, the chief executive officer now owns 887,835 shares of the company’s stock, valued at $144,583,929.75. This represents a 1.10 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. 2.00% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on the company. UBS Group boosted their price target on DaVita from $169.00 to $175.00 and gave the company a “buy” rating in a report on Thursday, August 8th. Truist Financial raised their price target on shares of DaVita from $165.00 to $175.00 and gave the stock a “hold” rating in a research report on Monday, October 7th. Bank of America lifted their price target on shares of DaVita from $139.00 to $145.00 and gave the company an “underperform” rating in a report on Wednesday, August 7th. Finally, Barclays increased their price objective on shares of DaVita from $150.00 to $164.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 31st. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat.com, DaVita has a consensus rating of “Hold” and a consensus price target of $161.80.

DaVita Stock Up 0.3 %

DVA stock opened at $166.17 on Friday. The company has a quick ratio of 1.33, a current ratio of 1.37 and a debt-to-equity ratio of 15.78. The firm’s 50-day simple moving average is $158.57 and its 200 day simple moving average is $149.31. The stock has a market cap of $13.63 billion, a PE ratio of 17.93, a price-to-earnings-growth ratio of 0.94 and a beta of 0.89. DaVita Inc. has a fifty-two week low of $99.18 and a fifty-two week high of $169.51.

DaVita (NYSE:DVA) last released its quarterly earnings results on Tuesday, October 29th. The company reported $2.59 earnings per share for the quarter, missing analysts’ consensus estimates of $2.76 by ($0.17). DaVita had a net margin of 6.53% and a return on equity of 88.18%. The business had revenue of $3.26 billion for the quarter, compared to the consensus estimate of $3.25 billion. During the same period last year, the firm posted $2.85 EPS. The business’s quarterly revenue was up 4.6% on a year-over-year basis. As a group, sell-side analysts predict that DaVita Inc. will post 9.71 EPS for the current year.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.